Effect of intravenous immunoglobulin in Lambert–Eaton myasthenic syndrome with small‐cell lung cancer: Correlation with the titer of anti–voltage‐gateo calcium channel antibody

This publication has 11 references indexed in Scilit:

• Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies
  The Lancet, 1993
• Clinical and electrophysiologic improvement in Lambert‐Eaton syndrome with intravenous immunoglobulin therapy
  Neurology, 1992
• Paraneoplastic Anti-Neuronal Nuclear IgG Autoantibodies (Type I) Localize Antigen in Small Cell Lung Carcinoma
  Mayo Clinic Proceedings, 1991
• Effect of ω-conotoxin GVIA on neurotransmitter release at the mouse neuromuscular junction
  Brain Research, 1991
• Calcium channel autoantibodies in the lambert‐eaton myasthenic syndrome
  Annals of Neurology, 1991
• Response of the Lambert‐Eaton myasthenic syndrome to treatment of associated small‐cell lung carcinoma
  Neurology, 1990
• Autoantibodies Bind Solubilized Calcium Channel-ω-Conotoxin Complexes From Small Cell Lung Carcinoma: A Diagnostic Aid for Lambert-Eaton Myasthenic Syndrome
  Mayo Clinic Proceedings, 1989
• SPECIFICITY OF CALCIUM CHANNEL AUTOANTIBODIES IN LAMBERT-EATON MYASTHENIC SYNDROME
  The Lancet, 1989
• Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder
  Trends in Neurosciences, 1989
• Plasma exchange and immunosuppressive drug treatment in the Lambert‐Eaton myasthenic syndrome
  Neurology, 1984